Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New application of bifidobacterium tetravaccine composition

A composition and the technology of Bifidobacterium infantis, applied in the field of medicine, can solve the problems of blood sugar, glycosylated hemoglobin and glycosylated albumin, etc.

Active Publication Date: 2017-08-18
HANGZHOU GRAND BIOLOGIC PHARMA INC
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, neither the patent nor the relevant literature mentions that the composition has a lowering effect on blood sugar, glycosylated hemoglobin and glycosylated albumin in diabetic patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of bifidobacterium tetravaccine composition
  • New application of bifidobacterium tetravaccine composition
  • New application of bifidobacterium tetravaccine composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0039] In order to clarify the effect of the bifidoquaternary live bacteria composition of the present invention on blood sugar, hypoglycemic hemoglobin and hypoglycemic albumin, the present embodiment further illustrates the present invention through animal experiments and clinical experiments, but the present invention is not limited by the embodiments. limits.

[0040] The bifidobacterium quadruple living bacteria composition of the present invention comprises bifidobacterium infantis, lactobacillus acidophilus, enterococcus faecalis and bacillus cereus.

[0041] Every gram of the bifidoquate live bacteria composition contains 5.0×10 Bifidobacterium infantis 6 pcs; Lactobacillus acidophilus is 2.5×10 6 pcs; Enterococcus faecalis 2.5×10 6 pcs; Bacillus cereus 2.5×10 5 indivual.

[0042] Among them, four kinds of bacteria were preserved in the General Biology Center of China Microorganism Collection Management Committee, address: No. 3, No. 1, Beichen West Road, Chaoyang ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses new application of a bifidobacterium tetravaccine composition, and belongs to the technical field of medicines. The invention discloses application of the bifidobacterium tetravaccine composition in preparing medicines or health-care foods or foods for assisting blood glucose reducing, application of the bifidobacterium tetravaccine composition in preparing medicines or health-care foods or foods for assisting glycated albumin reducing and assisting glycated hemoglobin reducing, and application of the bifidobacterium tetravaccine composition in preparing medicines or health-care foods or foods for blood glucose reducing for type II diabetes patients or hyperinsulinemia patients. The new application of the bifidobacterium tetravaccine composition has the advantages that the application range of the bifidobacterium tetravaccine composition is widened, and the clinical application range of the bifidobacterium tetravaccine composition is widened from the gastroenterology department to new diabetes endocrinology department; the composition is a probiotics microecological preparation, the components are harmless, and the side effect to a human body is avoided.

Description

technical field [0001] The invention relates to a new application of a bifid quadruple live bacteria composition, belonging to the technical field of medicine. Background technique [0002] According to IDF (International Diabetes Federation) statistics, the total population of diabetic patients is 98.4 million, neuropathy is 70%, and the incidence rate of diabetes is 60%. That is, the total population of diabetic patients with constipation in the country is 41 million. The total number of constipated diabetics in the population is 22 million. Most of the hypoglycemic drugs for the clinical treatment of diabetes are sulfonylurea insulin secretagogues, biguanides, α-glucosidase inhibitors, thiazolidinedione insulin sensitizers, dipeptidyl peptidase-4 inhibitors, Glucagon-like peptide-1 analogs, etc. These drugs can produce some side effects, such as hypoglycemia, gastrointestinal reactions (bloating, diarrhea), allergies, abnormal liver function, rashes, etc. [0003] Diabe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/747A23L33/135A61P3/10A61K35/745A61K35/744A61K35/742
CPCA23V2002/00A61K35/742A61K35/744A61K35/745A61K35/747A23V2200/3204A23V2200/32A23V2200/328A61K2300/00
Inventor 曹勇张方宁闫天文
Owner HANGZHOU GRAND BIOLOGIC PHARMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com